Immune Therapeutics Inc (OTCQB:IMUN)

0.063
Delayed Data
As of Jul 02
 -0.007 / -10.00%
Today’s Change
0.05
Today|||52-Week Range
0.44
-62.94%
Year-to-Date
No recent news for Immune Therapeutics Inc.

Today’s Trading

Previous close0.07
Today’s open0.06
Day’s range0.06 - 0.06
Volume16,901
Average volume (3 months)323,919
Market cap$11.6M
Dividend yield--
Data as of 3:55pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+73.51%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book6.16

Competitors

No competitors data available.

Financials

Last reporting dateMay 29, 2013
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$48.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Noreen Griffin
Chief Financial Officer
Peter J. Aronstam
Corporate headquarters
Orlando, Florida

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers